Literature DB >> 19608983

Estrogen contributes to gender differences in mouse ventricular repolarization.

Tomoaki Saito1, Andrea Ciobotaru, Jean Chrisostome Bopassa, Ligia Toro, Enrico Stefani, Mansoureh Eghbali.   

Abstract

RATIONALE: Fast-transient outward K(+) (I(to,f)) and ultrarapid delayed rectifier K(+) currents (I(K,slow), also known as I(Kur)) contribute to mouse cardiac repolarization. Gender studies on these currents have reported conflicting results.
OBJECTIVE: Key missing information in these studies is the estral stage of the animals. We revisited gender-related differences in K(+) currents, taking into consideration the females' estral stage. We hypothesized that changes in estrogen levels during the estral cycle could play a role in determining the densities of K(+) currents underlying ventricular repolarization. METHODS AND
RESULTS: Peak total K(+) current (I(K,total)) densities (pA/pF, at +40 mV) were much higher in males (48.6+/-3.0) versus females at estrus (27.2+/-2.3) but not at diestrus-2 (39.1+/-3.4). Underlying this change, I(to,f) and I(K,slow) were lower in females at estrus versus males and diestrus-2 (I(K,slow): male 21.9+/-1.8, estrus 14.6+/-0.6, diestrus-2 20.3+/-1.4; I(to,f): male 26.8+/-1.9, estrus 14.9+/-1.6, diestrus-2 22.1+/-2.1). Lower I(K,slow) in estrus was attributable to only I(K,slow)(1) reduction, without changes in I(K,slow)(2). Estrogen treatment of ovariectomized mice decreased I(K,total) (46.4+/-3.0 to 28.4+/-1.6), I(to,f) (26.6+/-1.6 to 12.8+/-1.0) and I(K,slow) (22.2+/-1.6 to 17.2+/-1.4). Transcript levels of Kv4.3 and Kv1.5 (underlying I(to,f) and I(K,slow), respectively) were lower in estrus versus diestrus-2 and male. In ovariectomized mice, estrogen treatment resulted in downregulation of Kv4.3 and Kv1.5 but not Kv4.2, KChIP2, or Kv2.1 transcripts. K(+) current reduction in high estrogenic conditions were associated with prolongation of the action potential duration and corrected QT interval.
CONCLUSION: Downregulation of Kv4.3 and Kv1.5 transcripts by estrogen are one mechanism defining gender-related differences in mouse ventricular repolarization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19608983      PMCID: PMC2921935          DOI: 10.1161/CIRCRESAHA.108.190041

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  26 in total

1.  Effects of progestin-estrogen replacement therapy on QT-dispersion in postmenopausal women.

Authors:  K Haseroth; K Seyffart; M Wehling; M Christ
Journal:  Int J Cardiol       Date:  2000-09-15       Impact factor: 4.164

2.  Hormone replacement therapy shortens QT dispersion in healthy postmenopausal women.

Authors:  A Yildirir; F Aybar; M G Kabakci; H Yarali; E Akgul; O Bukulmez; S L Tokgozoglu; T Gurgan; A Oto
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-07       Impact factor: 1.468

Review 3.  Recent advances in understanding sex differences in cardiac repolarization.

Authors:  Andrew F James; Stéphanie C M Choisy; Jules C Hancox
Journal:  Prog Biophys Mol Biol       Date:  2005-06-13       Impact factor: 3.667

4.  Reduced repolarization reserve in ventricular myocytes from female mice.

Authors:  Yuejin Wu; Mark E Anderson
Journal:  Cardiovasc Res       Date:  2002-02-15       Impact factor: 10.787

5.  Gender-based differences in cardiac repolarization in mouse ventricle.

Authors:  V Trépanier-Boulay; C St-Michel; A Tremblay; C Fiset
Journal:  Circ Res       Date:  2001-08-31       Impact factor: 17.367

6.  Influence of endogenous oestrogens on QT interval duration.

Authors:  Jean-Sébastien Hulot; Jean-Louis Démolis; Rachel Rivière; Soraya Strabach; Sophie Christin-Maitre; Christian Funck-Brentano
Journal:  Eur Heart J       Date:  2003-09       Impact factor: 29.983

7.  Effects of long-term hormone replacement therapy on QT and corrected QT dispersion during resting and peak exercise electrocardiography in post-menopausal women.

Authors:  Bülent B Altunkeser; Kurtulus Ozdemir; Abdullah Içli; Cetin Celik; Cemalettin Akyürek; Hasan Gök
Journal:  Jpn Heart J       Date:  2002-01

Review 8.  Mechanisms of estrogen action.

Authors:  S Nilsson; S Mäkelä; E Treuter; M Tujague; J Thomsen; G Andersson; E Enmark; K Pettersson; M Warner; J A Gustafsson
Journal:  Physiol Rev       Date:  2001-10       Impact factor: 37.312

9.  A prospective evaluation of the risk of QT prolongation with hormone replacement therapy: the atherosclerosis risk in communities study.

Authors:  Mercedes R Carnethon; Mary S Anthony; Wayne E Cascio; Aaron R Folsom; Pentti M Rautaharju; Duanping Liao; Gregory W Evans; Gerardo Heiss
Journal:  Ann Epidemiol       Date:  2003-08       Impact factor: 3.797

10.  Effect of androgen deficiency on mouse ventricular repolarization.

Authors:  Judith Brouillette; Véronique Trépanier-Boulay; Céline Fiset
Journal:  J Physiol       Date:  2003-01-15       Impact factor: 5.182

View more
  34 in total

Review 1.  Sex hormones and the QT interval: a review.

Authors:  Tara Sedlak; Chrisandra Shufelt; Carlos Iribarren; C Noel Bairey Merz
Journal:  J Womens Health (Larchmt)       Date:  2012-06-04       Impact factor: 2.681

2.  Cardiac vulnerability to ischemia/reperfusion injury drastically increases in late pregnancy.

Authors:  Jingyuan Li; Soban Umar; Andrea Iorga; Ji-Youn Youn; Yibin Wang; Vera Regitz-Zagrosek; Hua Cai; Mansoureh Eghbali
Journal:  Basic Res Cardiol       Date:  2012-05-31       Impact factor: 17.165

3.  Raloxifene inhibits cloned Kv4.3 channels in an estrogen receptor-independent manner.

Authors:  Yun Ju Chae; Dae Hun Kim; Hong Joon Lee; Ki-Wug Sung; Oh-Joo Kwon; Sang June Hahn
Journal:  Pflugers Arch       Date:  2014-09-18       Impact factor: 3.657

4.  Regulation of the female rat estrous cycle by a neural cell-specific epidermal growth factor-like repeat domain containing protein, NELL2.

Authors:  Byung Jun Ryu; Han Rae Kim; Jin Kwon Jeong; Byung Ju Lee
Journal:  Mol Cells       Date:  2011-06-01       Impact factor: 5.034

Review 5.  Back to your heart: ubiquitin proteasome system-regulated signal transduction.

Authors:  Andrea L Portbury; Sarah M Ronnebaum; Makhosazane Zungu; Cam Patterson; Monte S Willis
Journal:  J Mol Cell Cardiol       Date:  2011-11-06       Impact factor: 5.000

6.  Oral contraceptive use and the ECG: evidence of an adverse QT effect on corrected QT interval.

Authors:  Tara Sedlak; Chrisandra Shufelt; Carlos Iribarren; Liisa L Lyon; C Noel Bairey Merz
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-05-03       Impact factor: 1.468

7.  Complex Arrhythmia Syndrome in a Knock-In Mouse Model Carrier of the N98S Calm1 Mutation.

Authors:  Wen-Chin Tsai; Shuai Guo; Michael A Olaopa; Loren J Field; Jin Yang; Changyu Shen; Ching-Pin Chang; Peng-Sheng Chen; Michael Rubart
Journal:  Circulation       Date:  2020-09-15       Impact factor: 29.690

Review 8.  Effects of biological sex on the pathophysiology of the heart.

Authors:  Loubina Fazal; Feriel Azibani; Nicolas Vodovar; Alain Cohen Solal; Claude Delcayre; Jane-Lise Samuel
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

9.  Administration of 17β-Estradiol Improves Motoneuron Survival and Down-regulates Inflammasome Activation in Male SOD1(G93A) ALS Mice.

Authors:  Marius Heitzer; Sarah Kaiser; Mithila Kanagaratnam; Adib Zendedel; Philipp Hartmann; Cordian Beyer; Sonja Johann
Journal:  Mol Neurobiol       Date:  2016-12-12       Impact factor: 5.590

Review 10.  Sex differences in the mechanisms underlying long QT syndrome.

Authors:  Guy Salama; Glenna C L Bett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-06-27       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.